Whey Protein Comparisons for Blood Lipid Effects

ConditionCholesterol
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-59
SponsorMedinutra LLC

About this trial

The goal of this clinical trial is to learn if hydrolyzed whey protein can help serum cholesterol stay in normal range in adults. As a side inquiry, a few blood measures will be taken that are relevant to low level inflammation. The main questions the study aims to answer are:

* Will hydrolyzed whey lower serum cholesterol readings in adults with starting values in the upper end of normal to the lower end of elevated? * Will the hydrolyzed whey affect a general measure of inflammation and two measures of indirect relevance to inflammation?

Researchers will compare hydrolyzed whey to a conventional whey (a control protein not expected to affect serum cholesterol readings) to see if the hydrolyzed whey lowers serum cholesterol.

Participants will:

* Drink one protein beverage every day for 6 weeks; * Go to a LabCorp facility for a blood draw before and after the 6 weeks.

Eligibility criteria

Qualifiers

Cholesterol reading of 190 to 225 mg/dL

Age 21-59 years old

Disqualifiers

Uncontrolled diabetes

Hypothyroidism or other hormonal problems that have not stabilized

Any liver diseases being actively treated

Cancer

Trial design

Treatments tested in this trial

  • Standard whey
  • Hydrolyzed whey

Treatment groups

72 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Medinutra LLC

Lead sponsor

Dairy Management Inc.

Collaborator